Key result
Pre-procedural LAVI and E/e' predict AF recurrence after catheter ablation with an AUC of ~0.81.
Why the study?
To assess the value of pre-procedural echocardiography parameters for predicting recurrence following RFCA for AF and develop a predictive model.
Do pre-procedural echocardiographic parameters, specifically LAVI and E/e' ratio, predict atrial fibrillation recurrence in patients undergoing first-time radiofrequency catheter ablation?
Cohort (n=103)
No
Do pre-procedural echocardiographic parameters, specifically LAVI and E/e' ratio, predict atrial fibrillation recurrence in patients undergoing first-time radiofrequency catheter ablation?
Effect estimate: OR 2.545 (95% CI 1.344-4.821)
p-value: p=0.004
Pre-procedural left atrial volume index (LAVI) and E/e' ratio are independent predictors of atrial fibrillation recurrence after first-time radiofrequency catheter ablation, and their combination provides strong predictive value.
Supports echo-based risk stratification before AF ablation; hypothesis-generating pending external validation before routine adoption.
Objective: To assess the value of pre-procedural echocardiography (ECHO) parameters for predicting recurrence following radiofrequency catheter ablation (RFCA) for atrial fibrillation (AF) and develop a predictive model. Methods: In this retrospective study of 103 AF patients undergoing first-time RFCA, pre-ablation ECHO parameters were analyzed. The primary endpoint was AF recurrence after 3-month “blanking period”. Independent predictors were identified employing univariate and Firth-penalized multivariate logistic regression. Model performance was evaluated via ROC curve analysis, Bootstrap validation, calibration curves, and decision curve analysis (DCA). A predictive nomogram was generated based on the final model. Results: AF recurrence occurred in 32 patients (31.1%). Univariate analysis revealed that the recurrence group exhibited remarkably greater left atrial diameter (LAD), left atrial volume index (LAVI), mitral inflow early diastolic velocity (E-wave), E/A ratio, and E/e’ ratio, while the average early diastolic mitral annular tissue velocity (e’) was significantly lower (all P < 0.05). Multivariate analysis identified LAVI and the E/e’ ratio as independent risk factors (OR = 1.154, 95% CI: 1.057– 1.260, P = 0.001; OR = 2.545, 95% CI: 1.344– 4.821, P = 0.004, respectively). The AUC was 0.722 for LAVI and 0.764 for the E/e’ ratio. The combined predictive model incorporating both parameters yielded an AUC of 0.809 (95% CI: 0.726– 0.891), and demonstrated robust internal validation, good calibration, and positive clinical net benefit on DCA. Conclusion: Pre-procedural LAVI and E/e’ ratio are independent predictors of AF recurrence post-RFCA. The combined model demonstrates promising predictive performance, warranting further external validation before clinical application.
No takes yet. Share an insight, caveat, or question.
He et al. (2026) conducted a cohort in Atrial fibrillation (n=103). Radiofrequency catheter ablation (RFCA) was evaluated on Atrial fibrillation recurrence after 3-month blanking period (OR 2.545, 95% CI 1.344-4.821, p=0.004). Pre-procedural left atrial volume index and E/e' ratio independently predicted atrial fibrillation recurrence after radiofrequency catheter ablation, yielding a combined predictive model with an AUC of 0.809.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: